Rastogi, S., & Gupta, V. (2017). Eribulin Approval in Advanced Liposarcoma – Successful Drug or a Weaker Methodology? Indian J Med Paediatr Oncol.
Chicago-стиль цитированияRastogi, Sameer, and Vineet Gupta. "Eribulin Approval in Advanced Liposarcoma – Successful Drug or a Weaker Methodology?" Indian J Med Paediatr Oncol 2017.
MLA-цитированиеRastogi, Sameer, and Vineet Gupta. "Eribulin Approval in Advanced Liposarcoma – Successful Drug or a Weaker Methodology?" Indian J Med Paediatr Oncol 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.